BiotechTube

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™) + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Papillomavirus Infections

Conditions

Papillomavirus Infections

Trial Timeline

Mar 21, 2011 → Apr 15, 2013

NCT ID
NCT01245764

About Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™) + Placebo

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™) + Placebo is a phase 3 stage product being developed by Merck for Papillomavirus Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT01245764. Target conditions include Papillomavirus Infections.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01245764Phase 3Completed

Competing Products

20 competing products in Papillomavirus Infections

See all competitors
ProductCompanyStageHype Score
AAVLP-HPV + Placebo2A PharmaPhase 1
25
9vHPV vaccineMerckPhase 3
77
Human Papillomavirus 9-valent Vaccine, RecombinantMerckApproved
85
V503 (9-valent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] vaccine)MerckPhase 3
77
V503 + Comparator: Menactra™ (Concomitant) + Comparator: Adacel™ (Concomitant) + Comparator: Menactra™ (Non-Concomitant) + Comparator: Adacel™ (Non-concomitant)MerckPhase 3
77
Quadrivalent human papillomavirus vaccine on-time administration + Quadrivalent human papillomavirus vaccine delayed administrationMerckPre-clinical
23
GardasilMerckApproved
85
GardasilMerckPhase 2
52
9vHPV VaccineMerckPhase 3
77
9vHPV Vaccine + mRNA-1273 VaccineMerckPhase 3
77
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant VaccineMerckPhase 3
77
V503 + GARDASILMerckPhase 3
77
9vHPV VaccineMerckPhase 3
77
Gardasil vaccineMerckPre-clinical
23
V503MerckPhase 3
77
V503 Vaccine + REPEVAX™ (Concomitant) + REPEVAX™ (Non-concomitant)MerckPhase 3
77
9vHPV vaccineMerckPhase 3
77
Gardasil™ + PlaceboMerckPhase 3
77
V503 + GardasilMerckPhase 3
77
9vHPV vaccineMerckPhase 3
77

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85